Nexium Buyers Call Appeal Dismissal Bid 'Gamesmanship'
A group of Nexium buyers told the First Circuit on Friday that they didn't oppose AstraZeneca AB's bid to dismiss its class certification challenge in a pay-for-delay suit over the heartburn...To view the full article, register now.
Already a subscriber? Click here to view full article